- Home
- CATX vs SVIA Comparison
CATX vs SVIA Comparison
Compare CATX & SVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.30
Company Overview
Basic Information| Metric | CATX | SVIA |
|---|---|---|
| Founded | 1983 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 355.0M | 333.9M |
| IPO Year | 2018 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CATX | SVIA |
|---|---|---|
| Price | $2.30 | $3.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $12.29 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 1.4M |
| Earning Date | 11-05-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.96 | $3.68 |
| 52 Week High | $6.16 | $4.74 |
Technical Indicators
Market Signals| Indicator | CATX | SVIA |
|---|---|---|
| Relative Strength Index (RSI) | 38.38 | 49.15 |
| Support Level | N/A | $3.71 |
| Resistance Level | $3.00 | $4.00 |
| Average True Range (ATR) | 0.19 | 0.28 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 16.39 | 24.56 |
Price Performance
Historical Comparison CATX
SVIA
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.